116369-25-6

Basic information

• Product Name: 4-BROMO-3-TRIFLUOROMETHOXY-PHENYLAMINE
• Synonyms: 4-BROMO-3-TRIFLUOROMETHOXY-PHENYLAMINE;5-Amino-2-bromo-alpha,alpha,alpha-trifluoroanisole;4-Bromo-3-(trifluoromethoxy)aniline 95%;BenzenaMine, 4-broMo-3-(trifluoroMethoxy)-;4-bromo-3-(trifluoromethoxy)Benzenamine;4-Bromo-3-(trifluoromethoxy)aniline95%
• CAS NO: 116369-25-6
• Molecular Formula: C₇H₅BrF₃NO
• Molecular Weight: 256.02
• Mol File: 116369-25-6.mol

Chemical Properties

• Boiling Point: 227.8°C at 760 mmHg
• Flash Point: 91.6°C
• Appearance: /
• Density: 1.726g/cm³
• Vapor Pressure: 0.0758mmHg at 25°C
• Refractive Index: 1.523
• Storage Temp.: 2-8°C(protect from light)
• PKA: 2.66±0.10(Predicted)
• CAS DataBase Reference: 4-BROMO-3-TRIFLUOROMETHOXY-PHENYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-3-TRIFLUOROMETHOXY-PHENYLAMINE(116369-25-6)
• EPA Substance Registry System: 4-BROMO-3-TRIFLUOROMETHOXY-PHENYLAMINE(116369-25-6)

Safety Data

• Hazardous Substances Data: 116369-25-6(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
4-BROMO-3-TRIFLUOROMETHOXY-PHENYLAMINE is used as a key intermediate in the synthesis of various organic compounds for [application reason]. Its high reactivity and stability make it a valuable building block in the development of new chemical entities and pharmaceuticals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-BROMO-3-TRIFLUOROMETHOXY-PHENYLAMINE is used as a starting material for the synthesis of various drug candidates. Its unique chemical structure and properties allow for the creation of novel therapeutic agents with potential applications in treating various diseases and medical conditions.
Used in Chemical Research:
4-BROMO-3-TRIFLUOROMETHOXY-PHENYLAMINE is also used as a research tool in chemical laboratories for studying reaction mechanisms, exploring new synthetic routes, and understanding the properties of related compounds. Its reactivity and stability make it an ideal candidate for investigating various chemical transformations and reactions.
Used in Material Science:
In the field of material science, 4-BROMO-3-TRIFLUOROMETHOXY-PHENYLAMINE can be used as a component in the development of new materials with specific properties. Its unique structure and functional groups can contribute to the creation of materials with tailored characteristics for various applications, such as sensors, catalysts, or advanced materials for electronics and energy storage.

InChI:InChI=1/C7H5BrF3NO/c8-5-2-1-4(12)3-6(5)13-7(9,10)11/h1-3H,12H2

Upstream product

• 1535-73-5 m-trifluoromethoxyaniline 

Downstream Products

• 609783-03-1 1,1-dimethylethyl {4-bromo-3-[(trifluoromethyl)oxy]phenyl}carbamate 
• 1065604-15-0 C₇H₃BrClF₃O₃S 
• 1433280-30-8 N-(4-bromo-2-chloro-5-trifluoromethoxy-phenyl)-6-[(R)-4-(2,2-dimethyl-propionyl)-2-methyl-piperazin-1-yl]-nicotinamide 
• 1374892-55-3 N-(4-bromo-2-chloro-5-trifluoromethoxy-phenyl)-6-fluoro-nicotinamide 
• 1433280-32-0 (2S,4S)-2-{4-[5'-chloro-4'-({6-[(R)-4-(2,2-dimethyl-propionyl)-2-methyl-piperazin-1-yl]-pyridine-3-carbonyl}-amino)-2'-trifluoromethoxy-biphenyl-4-yl]-1H-imidazol-2-yl}-4-methyl-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 1433280-34-2 N-(4-bromo-2-chloro-5-trifluoromethoxy-phenyl)-6-[(R)-4-(3-hydroxy-2,2-dimethyl-propionyl)-2-methyl-piperazin-1-yl]-nicotinamide 
• 1433280-37-5 (2S,4S)-2-{4-[5'-chloro-4'-({6-[(R)-4-(3-hydroxy-2,2-dimethyl-propionyl)-2-methyl-piperazin-1-yl]-pyridine-3-carbonyl}-amino)-2'-trifluoromethoxy-biphenyl-4-yl]-1H-imidazol-2-yl}-4-methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 1374892-54-2 (R)-4-[5-(4-bromo-2-chloro-5-trifluoromethoxy-phenylcarbamoyl)-pyridin-2-yl]-3-methyl-piperazine-1-carboxylic acid tert-butyl ester 
• 1433280-51-3 (R)-(5-chloro-4-(6-(2-methyl-4-pivaloylpiperazin-1-yl)nicotinamido)-2-(trifluoromethoxy)phenyl)boronic acid 
• 1433281-23-2 ((S)-1-{(2S,4S)-4-carbamoyl-2-[4-(5'-chloro-4'-{[6-((R)-2-methyl-piperazin-1-yl)-pyridine-3-carbonyl]-amino}-2'-trifluoromethoxy-biphenyl-4-yl)-1H-imidazol-2-yl]-pyrrolidine-1-carbonyl}-2-methyl-propyl)-carbamic acid methyl ester 
• 1433280-29-5 (R)-4-[5-(5-chloro-4'-{2-[(2S,4S)-4-methoxy-1-((S)-2-methoxycarbonylamino-3-methyl-butyryl)-pyrrolidin-2-yl]-1H-imidazol-4-yl}-2-trifluoromethoxy-biphenyl-4-ylcarbamoyl)-pyridin-2-yl]-3-methyl-piperazine-1-carboxylic acid tert-butyl ester 
• 1433281-04-9 (R)-4-[5-(5-chloro-4'-{2-[(2S,4S)-1-((S)-2-methoxycarbonylamino-3-methyl-butyryl)-4-methyl-pyrrolidin-2-yl]-1H-imidazol-4-yl}-2-trifluoromethoxy-biphenyl-4-ylcarbamoyl)-pyridin-2-yl]-3-methylpiperazine-1-carboxylic acid tert-butyl ester 
• 1433281-16-3 N-(5-chloro-4'-(2-((2S,4S)-4-methylpyrrolidin-2-yl)-1H-imidazol-4-yl)-2-(trifluoromethoxy)-[1,1'-biphenyl]-4-yl)-6-((R)-2-methyl-4-pivaloylpiperazin-1-yl)nicotinamide 

Relevant articles and documents

INSECTICIDAL COMPOUNDS

A compound of formula (I) wherein A, p, R1, R3, R4, R5, and R8 are as defined in claim 1. Furthermore, the present invention relates to intermediates used to prepare compounds of formula (I), to metho

Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins

Overexpression of prosurvival proteins such as Bcl-2 and Bcl-XL has been correlated with tumorigenesis and resistance to chemotherapy, and thus, the development of antagonists of these proteins may provide a novel means for the treatment of can

BENZAMIDE DERIVATIVES

A compound represented by formula (1): wherein X is a single bond or a substituted or unsubstituted lower alkylene group; Z is a saturated or unsaturated monocyclic hydrocarbon ring group or the like; and each of R1, R2, R3 and R4, which may be the same or different, is a hydrogen atom, a halogen atom, a nitro group, a cyano group, a carboxyl group, a substituted or unsubstituted alkyl group, or the like, a prodrug of said compound, or a pharmaceutically acceptable salt of said compound or prodrug has inhibitory effect on Rho kinase and hence is useful for treating diseases which are such that morbidity due to them is expected to be improved by inhibition of Rho kinase and secondary effects such as inhibition of the Na+/H+ exchange transport system caused by the Rho kinase inhibition, for example, hypertension.